Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 3/20 | 1.00 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 4/20 | 0.53 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | PI4KA | P42356 | 1/20 | 0.50 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.50 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.50 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinolin-4-Amine SCHEMBL29493365 | 1.00 | NCF1 (1.00) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL5792741 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL29429801 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL28583906 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL6221275 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL4384971 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL14672386 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL30414452 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL20986747 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT | |
| Quinolin-4-Amine SCHEMBL3997934 | 0.98 | NCF1 (0.95) | NCF1LOXL2NR4A2SOS2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4944 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118772738-B | Self-adhesive coating for amorphous silicon steel sheet and preparation method thereof | Changzhou Jiuye Material Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026102264-A2 | HYDROXYCHLOROQUINE AS A PRETREATMENT TO ENHANCE AAV DELIVERY OF BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES | UNIVERSITY OF MIAMI (US) | 2026-05-15 | — | — | WO | claimed |
| US-20250332118-A1 | NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA | LIVIONEX INC (US) | 2025-10-30 | — | — | US | claimed |
| CN-120136781-A | ROR 1-targeted inhibitor and synthesis method and application thereof | 北京大学 | 2025-06-13 | — | — | CN | claimed |
| CN-120058675-A | Preparation and purification method and application of quinoline derivative with biological activity | 河南科技大学 | 2025-05-30 | — | — | CN | claimed |
| EP-4251617-B1 | (AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS | CHIESI FARM SPA (IT) | 2025-03-12 | — | — | EP | claimed |
| CN-119584967-A | Compositions and methods for treating hepatic porphyria with glycine transport inhibitors | 迪斯克医药公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119556538-A | Alkaline stripping liquid for silicon-based surface composite film and stripping method thereof | 湖北兴福电子材料股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-118979315-B | Ultraviolet-resistant moisture-absorbing fiber and preparation method thereof | 广东创时尚智能股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119432383-A | High-selectivity etching solution for radio frequency chip material | 湖北兴福电子材料股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| WO-1992001451-A1 | METHOD FOR KILLING HIV-INFECTED CELLS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-02-06 | — | — | WO | claimed |
| US-5019574-A | 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1991-05-28 | — | — | US | claimed |
| EP-0422097-A1 | METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO. | DAVIS MICHAEL H (US) | 1991-04-17 | — | — | EP | claimed |
| US-5006535-A | Substituted heterocylic 4-aminoquinoline derivatives as gastric acid secretion inhibitors | SMITH KLINE & FRENCH LABORATORIES LTD. (GB) | 1991-04-09 | — | — | US | claimed |
| WO-1990000055-A1 | METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO | DAVIS MICHAEL H (US) | 1990-01-11 | — | — | WO | claimed |
| EP-0305968-A2 | Compositions against protozoal diseases | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1989-03-08 | — | — | EP | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |
| EP-0035856-B1 | PHARMACEUTICAL AND DIETARY COMPOSITIONS | EFAMOL LIMITED (GB) | 1984-07-04 | — | — | EP | claimed |
| EP-0037175-A1 | Pharmaceutical compositions | EFAMOL LIMITED (GB) | 1981-10-07 | — | — | EP | claimed |
| EP-0035856-A2 | Pharmaceutical and dietary compositions | EFAMOL LIMITED (GB) | 1981-09-16 | — | — | EP | claimed |